poisar

Stocks · News reference

VolitionRx Limited Signs Letter of Intent with Missionpharma for NETosis Lateral Flow Technology

Fiscal.ai

VolitionRx Limited has executed a non-binding Letter of Intent with Missionpharma A/S to explore the development and distribution of its prototype Lateral Flow Technology for NETosis.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — VOLITIONRX LTD (VNRX)

    Filed: 2026-11-12 AccNo: 0001477932-26-006845 Size: 149 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers